Prothena's Schenk passes away

Antibody company Prothena Corp. plc (NASDAQ:PRTA) said President and CEO Dale Schenk passed away after a battle with pancreatic cancer.

The company's board intends to discuss a succession plan. When Prothena announced Monday that Schenk would take medical leave, it had said COO Gene Kinney would lead the company during his absence. ...